rFliC prolongs allograft survival in association with the activation of recipient Tregs in a TLR5-dependent manner

Flagellin Treatment Protects against Chemicals, Bacteria, Viruses, and Radiation

(2014) M. Vijay-Kumar et al.   JOURNAL OF IMMUNOLOGY

Inhibition of Pim2-prolonged skin allograft survival through the apoptosis regulation pathway

(2012) Hongtao Liu et al.   Cellular & Molecular Immunology

Evaluation of 131I-anti-MIF mAb as a reporter for allograft rejection

(2011) Ting Liang et al.   CLINICAL IMMUNOLOGY

An instructive role of donor macrophages in mixed chimeras in the induction of recipient CD4+ Foxp3+ Treg cells

(2011) Guangwei Liu et al.   IMMUNOLOGY AND CELL BIOLOGY

Toll-Like Receptor 5 Stimulation Protects Mice from AcuteClostridium difficileColitis

(2011) Irene Jarchum et al.   INFECTION AND IMMUNITY

Flagellin Enhances Saliva IgA Response and Protection of Anti-caries DNA Vaccine

(2011) W. Shi et al.   JOURNAL OF DENTAL RESEARCH

Enhanced Antigen Processing of Flagellin Fusion Proteins Promotes the Antigen-Specific CD8+ T Cell Response Independently of TLR5 and MyD88

(2011) J. T. Bates et al.   JOURNAL OF IMMUNOLOGY

Flagellin, a TLR5 Agonist, Reduces Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation Recipients While Enhancing Antiviral Immunity

(2011) Mohammad S. Hossain et al.   JOURNAL OF IMMUNOLOGY

Allospecific Regulatory Effects of Sirolimus and Tacrolimus in the Human Mixed Lymphocyte Reaction

(2011) Josh Levitsky et al.   TRANSPLANTATION

Flagellin Induces the Expression of Thymic Stromal Lymphopoietin in Human Keratinocytes via Toll-Like Receptor 5

(2010) Tuan Anh Le et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Flagellin as an Adjuvant: Cellular Mechanisms and Potential

(2010) S. B. Mizel et al.   JOURNAL OF IMMUNOLOGY

Flagellin delays spontaneous human neutrophil apoptosis

(2010) Gabriela V Salamone et al.   LABORATORY INVESTIGATION

Alloantigen specific T regulatory cells in transplant tolerance

(2009) Bruce M. Hall et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

An Agonist of Toll-Like Receptor 5 Has Radioprotective Activity in Mouse and Primate Models

(2008) L. G. Burdelya et al.   SCIENCE